The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Abbott Laboratories | Common | 002824100 | 47,206 | 431,145 | SH | SOLE | 431,145 | 0 | 0 | ||
AbbVie Inc. | Common | 00287Y109 | 66,407 | 619,759 | SH | SOLE | 619,759 | 0 | 0 | ||
ABIOMED, Inc. | Common | 003654100 | 3,505 | 10,812 | SH | SOLE | 10,812 | 0 | 0 | ||
AC Immune SA | Shares | H00263105 | 888 | 171,813 | SH | SOLE | 171,813 | 0 | 0 | ||
ACADIA Pharmaceuticals Inc. | Common | 004225108 | 17,737 | 331,789 | SH | SOLE | 331,789 | 0 | 0 | ||
Adaptive Biotechnologies Corporation | Common | 00650F109 | 16,912 | 286,013 | SH | SOLE | 286,013 | 0 | 0 | ||
Addus HomeCare Corporation | Common | 006739106 | 4,407 | 37,640 | SH | SOLE | 37,640 | 0 | 0 | ||
Aerie Pharmaceuticals, Inc. | Common | 00771V108 | 901 | 66,688 | SH | SOLE | 66,688 | 0 | 0 | ||
Affimed N.V. | Common | N01045108 | 1,560 | 268,019 | SH | SOLE | 268,019 | 0 | 0 | ||
Agilent Technologies, Inc. | Common | 00846U101 | 6,224 | 52,525 | SH | SOLE | 52,525 | 0 | 0 | ||
Alcon Inc. | Ordinary Shares | H01301128 | 2,064 | 31,286 | SH | SOLE | 31,286 | 0 | 0 | ||
Alexion Pharmaceuticals, Inc. | Common | 015351109 | 78,423 | 501,942 | SH | SOLE | 501,942 | 0 | 0 | ||
Align Technology, Inc. | Common | 016255101 | 5,366 | 10,041 | SH | SOLE | 10,041 | 0 | 0 | ||
Alkermes plc | Shares | G01767105 | 3,390 | 169,930 | SH | SOLE | 169,930 | 0 | 0 | ||
Allakos Inc. | Common | 01671P100 | 18,331 | 130,937 | SH | SOLE | 130,937 | 0 | 0 | ||
Allogene Therapeutics, Inc. | Common | 019770106 | 1,214 | 48,089 | SH | SOLE | 48,089 | 0 | 0 | ||
Alnylam Pharmaceuticals, Inc. | Common | 02043Q107 | 22,731 | 174,894 | SH | SOLE | 174,894 | 0 | 0 | ||
Amarin Corporation PLC | Sponsored ADR | 023111206 | 4,154 | 849,588 | SH | SOLE | 849,588 | 0 | 0 | ||
Amedisys, Inc. | Common | 023436108 | 5,689 | 19,395 | SH | SOLE | 19,395 | 0 | 0 | ||
Amgen Inc. | Common | 031162100 | 95,775 | 416,560 | SH | SOLE | 416,560 | 0 | 0 | ||
Amicus Therapeutics, Inc. | Common | 03152W109 | 9,366 | 405,626 | SH | SOLE | 405,626 | 0 | 0 | ||
Anthem, Inc. | Common | 036752103 | 11,923 | 37,133 | SH | SOLE | 37,133 | 0 | 0 | ||
Apellis Pharmaceuticals, Inc. | Common | 03753U106 | 12,356 | 216,017 | SH | SOLE | 216,017 | 0 | 0 | ||
ARCA biopharma, Inc. | Common | 00211Y506 | 130 | 32,461 | SH | SOLE | 32,461 | 0 | 0 | ||
Ardelyx, Inc. | Common | 039697107 | 3,932 | 607,698 | SH | SOLE | 607,698 | 0 | 0 | ||
Arena Pharmaceuticals, Inc. | Common | 040047607 | 19,436 | 252,971 | SH | SOLE | 252,971 | 0 | 0 | ||
Argenx SE | Sponsored ADR | 04016X101 | 18,142 | 61,687 | SH | SOLE | 61,687 | 0 | 0 | ||
Arrowhead Pharmaceuticals, Inc. | Common | 04280A100 | 10,196 | 132,886 | SH | SOLE | 132,886 | 0 | 0 | ||
Arvinas, Inc. | Common | 04335A105 | 6,239 | 73,459 | SH | SOLE | 73,459 | 0 | 0 | ||
Ascendis Pharma A/S | Sponsored ADR | 04351P101 | 16,052 | 96,246 | SH | SOLE | 96,246 | 0 | 0 | ||
Assertio Holdings, Inc. | Common | 04546C106 | 587 | 1,642,302 | SH | SOLE | 1,642,302 | 0 | 0 | ||
AstraZeneca PLC | Sponsored ADR | 046353108 | 17,213 | 344,333 | SH | SOLE | 344,333 | 0 | 0 | ||
Atreca, Inc. | Class A Common | 04965G109 | 5,692 | 352,424 | SH | SOLE | 352,424 | 0 | 0 | ||
Aurinia Pharmaceuticals Inc. | Common | 05156V102 | 4,157 | 300,611 | SH | SOLE | 300,611 | 0 | 0 | ||
Avadel Pharmaceuticals plc | Sponsored ADR | 05337M104 | 1,561 | 233,612 | SH | SOLE | 233,612 | 0 | 0 | ||
Axonics Modulation Technologies, Inc. | Common | 05465P101 | 4,032 | 80,760 | SH | SOLE | 80,760 | 0 | 0 | ||
Axsome Therapeutics, Inc. | Common | 05464T104 | 2,574 | 31,591 | SH | SOLE | 31,591 | 0 | 0 | ||
Bausch Health Companies Inc. | Common | 071734107 | 2,109 | 101,412 | SH | SOLE | 101,412 | 0 | 0 | ||
Becton, Dickinson and Company | Common | 075887109 | 32,960 | 131,723 | SH | SOLE | 131,723 | 0 | 0 | ||
BeiGene, Ltd. | Sponsored ADR | 07725L102 | 7,307 | 28,280 | SH | SOLE | 28,280 | 0 | 0 | ||
Bellicum Pharmaceuticals, Inc. | Common | 079481404 | 21 | 6,000 | SH | SOLE | 6,000 | 0 | 0 | ||
Bio-Techne Corporation | Common | 09073M104 | 16,421 | 51,710 | SH | SOLE | 51,710 | 0 | 0 | ||
Biogen Inc. | Common | 09062X103 | 60,442 | 246,844 | SH | SOLE | 246,844 | 0 | 0 | ||
BioMarin Pharmaceutical Inc. | Common | 09061G101 | 24,407 | 278,330 | SH | SOLE | 278,330 | 0 | 0 | ||
Blueprint Medicines Corporation | Common | 09627Y109 | 13,761 | 122,699 | SH | SOLE | 122,699 | 0 | 0 | ||
Boston Scientific Corporation | Common | 101137107 | 8,847 | 246,089 | SH | SOLE | 246,089 | 0 | 0 | ||
Bristol Myers Squibb Company | Common | 110122108 | 61,404 | 989,908 | SH | SOLE | 989,908 | 0 | 0 | ||
Bristol Myers Squibb Company | Right | 110122157 | 1,017 | 1,473,710 | SH | SOLE | 1,473,710 | 0 | 0 | ||
Celldex Therapeutics, Inc. | Common | 15117B202 | 124 | 7,053 | SH | SOLE | 7,053 | 0 | 0 | ||
Cellectis | Sponsored ADR | 15117K103 | 324 | 11,955 | SH | SOLE | 11,955 | 0 | 0 | ||
Centene Corporation | Common | 15135B101 | 5,051 | 84,145 | SH | SOLE | 84,145 | 0 | 0 | ||
Charles River Laboratories International, Inc. | Common | 159864107 | 7,035 | 28,154 | SH | SOLE | 28,154 | 0 | 0 | ||
ChemoCentryx, Inc. | Common | 16383L106 | 8,944 | 144,447 | SH | SOLE | 144,447 | 0 | 0 | ||
Cigna Corporation | Common | 125523100 | 28,253 | 135,712 | SH | SOLE | 135,712 | 0 | 0 | ||
Clearside Biomedical, Inc. | Common | 185063104 | 453 | 165,330 | SH | SOLE | 165,330 | 0 | 0 | ||
Cogent Biosciences, Inc. | Common | 19240Q201 | 6,039 | 537,742 | SH | SOLE | 537,742 | 0 | 0 | ||
Community Health Systems, Inc. | Common | 203668108 | 875 | 117,735 | SH | SOLE | 117,735 | 0 | 0 | ||
Community Healthcare Trust Incorporated | Common | 20369C106 | 702 | 14,900 | SH | SOLE | 14,900 | 0 | 0 | ||
Corbus Pharmaceuticals Holdings, Inc. | Common | 21833P103 | 517 | 413,481 | SH | SOLE | 413,481 | 0 | 0 | ||
CRISPR Therapeutics AG | Namen AKT | H17182108 | 11,670 | 76,222 | SH | SOLE | 76,222 | 0 | 0 | ||
CVS Health Corporation | Common | 126650100 | 15,026 | 219,995 | SH | SOLE | 219,995 | 0 | 0 | ||
CymaBay Therapeutics, Inc. | Common | 23257D103 | 506 | 88,102 | SH | SOLE | 88,102 | 0 | 0 | ||
Danaher Corporation | Common | 235851102 | 48,835 | 219,840 | SH | SOLE | 219,840 | 0 | 0 | ||
Deciphera Pharmaceuticals, Inc. | Common | 24344T101 | 3,502 | 61,370 | SH | SOLE | 61,370 | 0 | 0 | ||
Denali Therapeutics Inc. | Common | 24823R105 | 6,059 | 72,333 | SH | SOLE | 72,333 | 0 | 0 | ||
DENTSPLY SIRONA Inc. | Common | 24906P109 | 19,160 | 365,927 | SH | SOLE | 365,927 | 0 | 0 | ||
DexCom, Inc. | Common | 252131107 | 27,597 | 74,643 | SH | SOLE | 74,643 | 0 | 0 | ||
Dicerna Pharmaceuticals, Inc. | Common | 253031108 | 1,501 | 68,150 | SH | SOLE | 68,150 | 0 | 0 | ||
Diversified Healthcare Trust | Common | 25525P107 | 1,474 | 357,720 | SH | SOLE | 357,720 | 0 | 0 | ||
Edwards Lifesciences Corporation | Common | 28176E108 | 24,172 | 264,955 | SH | SOLE | 264,955 | 0 | 0 | ||
Eidos Therapeutics, Inc. | Common | 28249H104 | 2,632 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
Eli Lilly and Company | Common | 532457108 | 40,106 | 237,537 | SH | SOLE | 237,537 | 0 | 0 | ||
Endo International plc | Shares | G30401106 | 3,817 | 531,570 | SH | SOLE | 531,570 | 0 | 0 | ||
Esperion Therapeutics, Inc. | Common | 29664W105 | 1,081 | 41,577 | SH | SOLE | 41,577 | 0 | 0 | ||
Exact Sciences Corporation | Common | 30063P105 | 8,413 | 63,502 | SH | SOLE | 63,502 | 0 | 0 | ||
Exelixis, Inc. | Common | 30161Q104 | 25,218 | 1,256,520 | SH | SOLE | 1,256,520 | 0 | 0 | ||
Fate Therapeutics, Inc. | Common | 31189P102 | 15,123 | 166,317 | SH | SOLE | 166,317 | 0 | 0 | ||
FibroGen, Inc. | Common | 31572Q808 | 7,205 | 194,270 | SH | SOLE | 194,270 | 0 | 0 | ||
Five Star Senior Living Inc. | Common | 33832D205 | 167 | 24,237 | SH | SOLE | 24,237 | 0 | 0 | ||
Forma Therapeutics Holdings, Inc. | Shares | 34633R104 | 5,229 | 149,825 | SH | SOLE | 149,825 | 0 | 0 | ||
Galera Therapeutics, Inc. | Common | 36338D108 | 10,658 | 1,041,845 | SH | SOLE | 1,041,845 | 0 | 0 | ||
Genmab A/S | Sponsored ADS | 372303206 | 10,518 | 258,672 | SH | SOLE | 258,672 | 0 | 0 | ||
Gilead Sciences, Inc. | Common | 375558103 | 81,877 | 1,405,371 | SH | SOLE | 1,405,371 | 0 | 0 | ||
Global Medical REIT Inc. | Common | 37954A204 | 2,284 | 174,897 | SH | SOLE | 174,897 | 0 | 0 | ||
Grifols, S.A. | Sponsored ADR | 398438408 | 874 | 47,373 | SH | SOLE | 47,373 | 0 | 0 | ||
Gritstone Oncology, Inc. | Common | 39868T105 | 1,651 | 419,005 | SH | SOLE | 419,005 | 0 | 0 | ||
Guardant Health, Inc. | Common | 40131M109 | 15,189 | 117,852 | SH | SOLE | 117,852 | 0 | 0 | ||
Harpoon Therapeutics, Inc. | Common | 41358P106 | 1,768 | 106,419 | SH | SOLE | 106,419 | 0 | 0 | ||
HCA Healthcare, Inc. | Common | 40412C101 | 28,796 | 175,097 | SH | SOLE | 175,097 | 0 | 0 | ||
Health Care Select Sector SPDR Fund | SBI Healthcare | 81369Y209 | 1,141 | 10,055 | SH | SOLE | 10,055 | 0 | 0 | ||
Healthcare Realty Trust Incorporated | Common | 421946104 | 3,079 | 104,024 | SH | SOLE | 104,024 | 0 | 0 | ||
Healthcare Trust of America, Inc. | Common | 42225P501 | 1,946 | 70,662 | SH | SOLE | 70,662 | 0 | 0 | ||
Healthpeak Properties, Inc. | Common | 42250P103 | 4,546 | 150,392 | SH | SOLE | 150,392 | 0 | 0 | ||
Helix Acquisition Corp. | Class A Common | G4444C102 | 2,708 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
Heron Therapeutics, Inc. | Common | 427746102 | 2,776 | 131,183 | SH | SOLE | 131,183 | 0 | 0 | ||
Hologic, Inc. | Common | 436440101 | 2,372 | 32,564 | SH | SOLE | 32,564 | 0 | 0 | ||
Horizon Therapeutics plc | Shares | G46188101 | 34,016 | 465,016 | SH | SOLE | 465,016 | 0 | 0 | ||
Humana Inc. | Common | 444859102 | 33,973 | 82,807 | SH | SOLE | 82,807 | 0 | 0 | ||
IDEXX Laboratories, Inc. | Common | 45168D104 | 17,402 | 34,814 | SH | SOLE | 34,814 | 0 | 0 | ||
Illumina, Inc. | Common | 452327109 | 95,272 | 257,493 | SH | SOLE | 257,493 | 0 | 0 | ||
ImmunoGen, Inc. | Common | 45253H101 | 1,085 | 168,190 | SH | SOLE | 168,190 | 0 | 0 | ||
Incyte Corporation | Common | 45337C102 | 8,111 | 93,257 | SH | SOLE | 93,257 | 0 | 0 | ||
Inogen, Inc. | Common | 45780L104 | 2,297 | 51,406 | SH | SOLE | 51,406 | 0 | 0 | ||
Insmed Incorporated | Common | 457669307 | 3,275 | 98,387 | SH | SOLE | 98,387 | 0 | 0 | ||
Intercept Pharmaceuticals, Inc. | Common | 45845P108 | 1,904 | 77,067 | SH | SOLE | 77,067 | 0 | 0 | ||
Intra-Cellular Therapies, Inc. | Common | 46116X101 | 11,644 | 366,176 | SH | SOLE | 366,176 | 0 | 0 | ||
Intuitive Surgical, Inc. | Common | 46120E602 | 17,422 | 21,296 | SH | SOLE | 21,296 | 0 | 0 | ||
Ionis Pharmaceuticals, Inc. | Common | 462222100 | 10,924 | 193,201 | SH | SOLE | 193,201 | 0 | 0 | ||
Iovance Biotherapeutics, Inc. | Common | 462260100 | 12,578 | 271,073 | SH | SOLE | 271,073 | 0 | 0 | ||
IQVIA Holdings Inc. | Common | 46266C105 | 13,629 | 76,066 | SH | SOLE | 76,066 | 0 | 0 | ||
Jazz Pharmaceuticals plc | Shares | G50871105 | 11,134 | 67,456 | SH | SOLE | 67,456 | 0 | 0 | ||
Johnson & Johnson | Common | 478160104 | 86,056 | 546,805 | SH | SOLE | 546,805 | 0 | 0 | ||
Kadmon Holdings, Inc. | Common | 48283N106 | 2,963 | 714,008 | SH | SOLE | 714,008 | 0 | 0 | ||
Karuna Therapeutics, Inc. | Common | 48576A100 | 8,659 | 85,236 | SH | SOLE | 85,236 | 0 | 0 | ||
Karyopharm Therapeutics Inc. | Common | 48576U106 | 1,018 | 65,743 | SH | SOLE | 65,743 | 0 | 0 | ||
Koninklijke Philips N.V. | NY Reg Sh | 500472303 | 3,084 | 56,927 | SH | SOLE | 56,927 | 0 | 0 | ||
Kura Oncology, Inc. | Common | 50127T109 | 8,931 | 273,463 | SH | SOLE | 273,463 | 0 | 0 | ||
Laboratory Corporation of America Holdings | Sponsored ADR | 50540R409 | 13,150 | 64,603 | SH | SOLE | 64,603 | 0 | 0 | ||
LTC Properties, Inc. | Common | 502175102 | 7,093 | 182,293 | SH | SOLE | 182,293 | 0 | 0 | ||
Madrigal Pharmaceuticals, Inc. | Common | 558868105 | 1,483 | 13,340 | SH | SOLE | 13,340 | 0 | 0 | ||
Magenta Therapeutics, Inc. | Common | 55910K108 | 1,509 | 192,431 | SH | SOLE | 192,431 | 0 | 0 | ||
McKesson Corp. | Common | 58155Q103 | 22,688 | 130,448 | SH | SOLE | 130,448 | 0 | 0 | ||
Medical Properties Trust, Inc. | Common | 58463J304 | 8,972 | 411,743 | SH | SOLE | 411,743 | 0 | 0 | ||
Medpace Holdings, Inc. | Common | 58506Q109 | 2,627 | 18,871 | SH | SOLE | 18,871 | 0 | 0 | ||
Medtronic plc | Shares | G5960L103 | 62,660 | 534,914 | SH | SOLE | 534,914 | 0 | 0 | ||
Merck & Co., Inc. | Common | 58933Y105 | 45,882 | 560,903 | SH | SOLE | 560,903 | 0 | 0 | ||
Mettler-Toledo International Inc. | Common | 592688105 | 11,169 | 9,800 | SH | SOLE | 9,800 | 0 | 0 | ||
Milestone Pharmaceuticals Inc. | Common | 59935V107 | 1,699 | 253,610 | SH | SOLE | 253,610 | 0 | 0 | ||
Mirati Therapeutics, Inc. | Common | 60468T105 | 18,402 | 83,784 | SH | SOLE | 83,784 | 0 | 0 | ||
Moderna, Inc. | Common | 60770K107 | 25,929 | 248,192 | SH | SOLE | 248,192 | 0 | 0 | ||
Molecular Templates, Inc. | Common | 608550109 | 2,064 | 219,822 | SH | SOLE | 219,822 | 0 | 0 | ||
Molina Healthcare, Inc. | Common | 60855R100 | 8,458 | 39,769 | SH | SOLE | 39,769 | 0 | 0 | ||
MorphoSys AG | Sponsored ADS | 617760202 | 2,320 | 81,867 | SH | SOLE | 81,867 | 0 | 0 | ||
National Health Investors, Inc. | Common | 63633D104 | 694 | 10,038 | SH | SOLE | 10,038 | 0 | 0 | ||
Nektar Therapeutics | Common | 640268108 | 3,067 | 180,438 | SH | SOLE | 180,438 | 0 | 0 | ||
Neurocrine Biosciences, Inc. | Common | 64125C109 | 28,202 | 294,234 | SH | SOLE | 294,234 | 0 | 0 | ||
New Senior Investment Group Inc. | Common | 648691103 | 1,328 | 256,398 | SH | SOLE | 256,398 | 0 | 0 | ||
Novartis AG | Sponsored ADR | 66987V109 | 13,647 | 144,525 | SH | SOLE | 144,525 | 0 | 0 | ||
Novavax, Inc. | Common | 670002401 | 8,540 | 76,585 | SH | SOLE | 76,585 | 0 | 0 | ||
Novo Nordisk A/S | Sponsored ADR | 670100205 | 4,534 | 64,906 | SH | SOLE | 64,906 | 0 | 0 | ||
NovoCure Limited | Ordinary Shares | G6674U108 | 15,213 | 87,918 | SH | SOLE | 87,918 | 0 | 0 | ||
NuCana plc | Sponsored ADR | 67022C106 | 2,068 | 460,672 | SH | SOLE | 460,672 | 0 | 0 | ||
Omega Healthcare Investors, Inc. | Common | 681936100 | 11,130 | 306,433 | SH | SOLE | 306,433 | 0 | 0 | ||
Ovid Therapeutics Inc. | Sponsored ADR | 690469101 | 861 | 372,733 | SH | SOLE | 372,733 | 0 | 0 | ||
Owens & Minor, Inc. | Common | 690732102 | 7,196 | 266,023 | SH | SOLE | 266,023 | 0 | 0 | ||
PerkinElmer, Inc. | Common | 714046109 | 5,323 | 37,094 | SH | SOLE | 37,094 | 0 | 0 | ||
Perrigo Company plc | Shares | G97822103 | 2,291 | 51,224 | SH | SOLE | 51,224 | 0 | 0 | ||
Pfizer Inc. | Common | 717081103 | 25,961 | 705,259 | SH | SOLE | 705,259 | 0 | 0 | ||
Physicians Realty Trust | Common | 71943U104 | 8,824 | 495,733 | SH | SOLE | 495,733 | 0 | 0 | ||
Pieris Pharmaceuticals, Inc. | Common | 720795103 | 3,623 | 1,449,269 | SH | SOLE | 1,449,269 | 0 | 0 | ||
PRA Health Sciences, Inc. | Common | 69354M108 | 22,057 | 175,838 | SH | SOLE | 175,838 | 0 | 0 | ||
Praxis Precision Medicines, Inc. | Common | 74006W108 | 4,127 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
Quest Diagnostics Incorporated | Common | 74834L100 | 13,068 | 109,659 | SH | SOLE | 109,659 | 0 | 0 | ||
Reata Pharmaceuticals, Inc. | Class A | 75615P103 | 4,725 | 38,219 | SH | SOLE | 38,219 | 0 | 0 | ||
Regeneron Pharmaceuticals, Inc. | Common | 75886F107 | 86,663 | 179,385 | SH | SOLE | 179,385 | 0 | 0 | ||
REGENXBIO Inc. | Common | 75901B107 | 984 | 21,700 | SH | SOLE | 21,700 | 0 | 0 | ||
ResMed Inc. | Common | 761152107 | 28,131 | 132,344 | SH | SOLE | 132,344 | 0 | 0 | ||
Revance Therapeutics, Inc. | Common | 761330109 | 6,059 | 213,808 | SH | SOLE | 213,808 | 0 | 0 | ||
Sabra Health Care REIT, Inc. | Common | 78573L106 | 8,870 | 510,660 | SH | SOLE | 510,660 | 0 | 0 | ||
Sage Therapeutics, Inc. | Common | 78667J108 | 13,153 | 152,040 | SH | SOLE | 152,040 | 0 | 0 | ||
Sanofi | Sponsored ADR | 80105N105 | 3,963 | 81,554 | SH | SOLE | 81,554 | 0 | 0 | ||
Sarepta Therapeutics, Inc. | Common | 803607100 | 35,204 | 206,487 | SH | SOLE | 206,487 | 0 | 0 | ||
Scholar Rock Holding Corporation | Common | 80706P103 | 5,634 | 116,094 | SH | SOLE | 116,094 | 0 | 0 | ||
Seagen Inc. | Common | 81181C104 | 51,424 | 293,619 | SH | SOLE | 293,619 | 0 | 0 | ||
Smith & Nephew plc | Shares | 83175M205 | 4,198 | 99,560 | SH | SOLE | 99,560 | 0 | 0 | ||
Spectrum Pharmaceuticals, Inc. | Common | 84763A108 | 391 | 114,670 | SH | SOLE | 114,670 | 0 | 0 | ||
STERIS plc | Shares | G8473T100 | 24,030 | 126,779 | SH | SOLE | 126,779 | 0 | 0 | ||
Stryker Corporation | Common | 863667101 | 37,572 | 153,330 | SH | SOLE | 153,330 | 0 | 0 | ||
Sutro Biopharma, Inc. | Common | 869367102 | 15,252 | 702,523 | SH | SOLE | 702,523 | 0 | 0 | ||
Syneos Health, Inc. | Class A | 87166B102 | 13,295 | 195,136 | SH | SOLE | 195,136 | 0 | 0 | ||
Takeda Pharmaceutical Company Limited | Sponsored ADS | 874060205 | 3,825 | 210,146 | SH | SOLE | 210,146 | 0 | 0 | ||
Teladoc Health, Inc. | Common | 87918A105 | 11,302 | 56,520 | SH | SOLE | 56,520 | 0 | 0 | ||
Teleflex Incorporated | Common | 879369106 | 6,195 | 15,052 | SH | SOLE | 15,052 | 0 | 0 | ||
Tenet Healthcare Corporation | Common | 88033G407 | 3,304 | 82,736 | SH | SOLE | 82,736 | 0 | 0 | ||
Tetraphase Pharmaceuticals, Inc. | Common | 881CVR013 | 9 | 42,965 | SH | SOLE | 42,965 | 0 | 0 | ||
Teva Pharmaceutical Industries Ltd. | Sponsored ADR | 881624209 | 7,045 | 730,051 | SH | SOLE | 730,051 | 0 | 0 | ||
TG Therapeutics, Inc. | Common | 88322Q108 | 6,933 | 133,269 | SH | SOLE | 133,269 | 0 | 0 | ||
Theravance Biopharma, Inc. | Common | G8807B106 | 8,108 | 456,296 | SH | SOLE | 456,296 | 0 | 0 | ||
Thermo Fisher Scientific Inc. | Common | 883556102 | 59,412 | 127,553 | SH | SOLE | 127,553 | 0 | 0 | ||
Trillium Therapeutics Inc. | Common | 89620X506 | 12,030 | 817,784 | SH | SOLE | 817,784 | 0 | 0 | ||
Turning Point Therapeutics, Inc. | Common | 90041T108 | 14,540 | 119,324 | SH | SOLE | 119,324 | 0 | 0 | ||
Ultragenyx Pharmaceutical Inc. | Common | 90400D108 | 13,494 | 97,480 | SH | SOLE | 97,480 | 0 | 0 | ||
uniQure N.V. | Shares | N90064101 | 4,516 | 125,003 | SH | SOLE | 125,003 | 0 | 0 | ||
United Therapeutics Corporation | Class B | 91307C102 | 9,641 | 63,513 | SH | SOLE | 63,513 | 0 | 0 | ||
Unitedhealth Group Incorporated | Common | 91324P102 | 76,864 | 219,185 | SH | SOLE | 219,185 | 0 | 0 | ||
Universal Health Realty Income Trust | Shares | 91359E105 | 724 | 11,258 | SH | SOLE | 11,258 | 0 | 0 | ||
Ventas, Inc. | Common | 92276F100 | 10,206 | 208,108 | SH | SOLE | 208,108 | 0 | 0 | ||
Verona Pharma plc | Sponsored ADR | 925050106 | 5,263 | 751,905 | SH | SOLE | 751,905 | 0 | 0 | ||
Vertex Pharmaceuticals Incorporated | Common | 92532F100 | 72,157 | 305,310 | SH | SOLE | 305,310 | 0 | 0 | ||
Viatris Inc. | Common | 92556V106 | 251 | 13,400 | SH | SOLE | 13,400 | 0 | 0 | ||
VYNE Therapeutics Inc. | Common | 92941V100 | 856 | 541,584 | SH | SOLE | 541,584 | 0 | 0 | ||
Waters Corporation | Common | 941848103 | 27,095 | 109,510 | SH | SOLE | 109,510 | 0 | 0 | ||
Welltower Inc. | Common | 95040Q104 | 13,123 | 203,083 | SH | SOLE | 203,083 | 0 | 0 | ||
Xencor, Inc. | Common | 98401F105 | 6,467 | 148,231 | SH | SOLE | 148,231 | 0 | 0 | ||
Y-mAbs Therapeutics, Inc. | Common | 984241109 | 3,790 | 76,548 | SH | SOLE | 76,548 | 0 | 0 | ||
Zai Lab Limited | ADR | 98887Q104 | 5,078 | 37,523 | SH | SOLE | 37,523 | 0 | 0 | ||
Zimmer Biomet Holdings, Inc. | Common | 98956P102 | 32,977 | 214,014 | SH | SOLE | 214,014 | 0 | 0 | ||
Zoetis Inc. | Class A | 98978V103 | 9,354 | 56,521 | SH | SOLE | 56,521 | 0 | 0 | ||
Zogenix, Inc. | Common | 98978L204 | 1,779 | 88,977 | SH | SOLE | 88,977 | 0 | 0 | ||
Zymeworks Inc. | Common | 98985W102 | 2,644 | 55,938 | SH | SOLE | 55,938 | 0 | 0 |